Who Owns Jasper Therapeutics Stock?
NASDAQ: JSPRHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 1:10 PM ET
Ownership breakdown
- Held by institutions
- 39.27%
- Held by insiders
- 2.86%
- Institutional holders
- 54
- Institutions 39.3%
- Insiders 2.9%
- Public and other 57.9%
Who owns Jasper Therapeutics stock?
Institutional investors own about 39.3% of Jasper Therapeutics's shares, spread across 54 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 2.86% of JSPR.
The largest institutional holders are Velan Capital Investment Management LP (16.04%), Acorn Capital Advisors, LLC (8.64%) and Kingdon Capital Management LLC (8.13%). Together, the top 10 institutions control 63.4% of shares outstanding. In their latest filings, 2 of the top 10 institutions increased their JSPR positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of JSPR
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Velan Capital Investment Management LP | 5.34M | 16.04% | 0.0% |
| Acorn Capital Advisors, LLC | 2.88M | 8.64% | +1.9% |
| Kingdon Capital Management LLC | 2.70M | 8.13% | 0.0% |
| Vanguard Capital Management LLC | 2.34M | 7.04% | -0.1% |
| Rock Springs Capital Management, LP | 2.20M | 6.62% | 0.0% |
| Carlyle Group Inc. | 2.13M | 6.41% | 0.0% |
| GSA Capital Partners LLP | 1.07M | 3.21% | +2701.8% |
| Millennium Management Llc | 973.87K | 2.93% | -69.9% |
| Lion Point Capital, LP | 930.00K | 2.79% | 0.0% |
| Geode Capital Management, LLC | 527.62K | 1.59% | -17.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of JSPR
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 1.67M | 5.01% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 624.06K | 1.88% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 127.53K | 0.38% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 53.20K | 0.16% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 49.90K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 34.11K | 0.10% |
| ADVISORS' INNER CIRCLE III-Knights of Columbus U.S. All Cap Index Fund | 155 | 0.00% |
Frequently asked questions
Who is the largest shareholder of Jasper Therapeutics?
Velan Capital Investment Management LP is the largest institutional shareholder of JSPR, owning 16.04% of shares outstanding (5.34M shares) as of its latest 13F filing.
What percentage of Jasper Therapeutics is owned by institutions?
Institutions own about 39.3% of JSPR shares and 40.4% of the public float.
How much of Jasper Therapeutics do insiders own?
Insiders, such as officers and directors, own about 2.86% of JSPR shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.